Related Experiment Video
Updated: Aug 11, 2026

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
Published on: October 16, 2018
Virologic and host characteristics of human immunodeficiency virus type 1-infected pediatric long term survivors
Louis Alexander1, Lisa Cuchura, B Joyce Simpson
1Department of Epidemiology and Public Health, Yale University School of Medicine, 60 College Street, New Haven, CT 06520, USA. louis.alexander@yale.edu
Insights
Host and viral factors, not just limited treatment, contribute to slow human immunodeficiency virus type 1 (HIV-1) progression in children. Genetic factors like CCR2 polymorphism and viral mutations appear crucial for long-term non-progressive HIV-1 infection.
Area of Science:
- Pediatric Infectious Diseases
- Virology
- Immunogenetics
Background:
- Limited data exists on factors influencing varying clinical progression rates in pediatric human immunodeficiency virus type 1 (HIV-1) infection.
- Understanding these determinants is crucial for managing HIV-1 in children.
Purpose of the Study:
- To investigate whether viral and host factors known to be associated with nonprogressive HIV-1 infection in adults are also present in children with minimal disease progression.
- To identify potential mechanisms contributing to long-term non-progressive HIV-1 infection in vertically infected youths receiving minimal antiretroviral therapy.
Main Methods:
- Characterization of 5 vertically HIV-1 infected youths (ages 12-18) with minimal disease progression and low antiretroviral exposure.
- Analysis of plasma HIV-1 RNA loads, CD4 T-lymphocyte counts/percentages.
- Sequencing of predominant HIV-1 strains to identify resistance markers and replication-inhibiting mutations (Gag, Vif).
- Genotyping for CCR2 polymorphism (64I) and analysis of histocompatibility leukocyte antigen (HLA) phenotypes (DQ1, DR/DQ1).
Main Results:
- All 5 long-term survivors maintained low HIV-1 RNA levels and normal CD4 counts.
- 4 out of 5 harbored HIV-1 with therapy resistance markers; 2 had viral isolates with Gag/Vif insertions inhibiting replication.
- 2 individuals were heterozygous for CCR2 64I polymorphism, associated with slower AIDS progression in adults.
- All 5 expressed HLA DQ1, with 2 showing unusual DR/DQ1 phenotypes.
Conclusions:
- Limited antiretroviral therapy alone does not explain the benign clinical status of these long-term survivors.
- Host genetic factors (e.g., CCR2 polymorphism, HLA types) and viral characteristics (e.g., reduced replicative capacity) likely contribute to controlling HIV-1 progression.
- No single virologic or host factor fully explains the non-progressive phenotype in all cases, suggesting a multifactorial etiology similar to adults.
Background:
There are limited data concerning determinants of varying clinical progression rates in human immunodeficiency virus type 1 (HIV-1)-infected children. Therefore, we sought to determine whether viral or host factors associated with nonprogressive HIV-1 infection in adults play a role in limiting progression of infection in 5 vertically infected youths, ages 12-18 years, who have displayed no signs of advanced HIV-1 disease or acquired immunodeficiency syndrome despite having received minimal treatment with antiretroviral drugs.
Results:
The 5 individuals, whom we characterize as long term survivors, have maintained low loads of HIV-1 RNA in plasma when compared to many of their peers, and have also maintained normal and stable CD4 T-lymphocyte numbers and percentages throughout their lives. Determination of their predominant HIV-1 sequences revealed that 4 of 5 patients harbor virus with markers of resistance to their therapy (one was never treated). Furthermore 2 harbored viral isolates that contained insertions in Gag or Vif that inhibit HIV-1 replication. Moreover, 2 were found to be heterozygous for the CCR2 polymorphism 64I, a genotype associated with slower progression to acquired immunodeficiency syndrome in adults. All 5 expressed the histocompatibility leukocyte antigen DQ1 and 2 had unusual DR/DQ1 phenotypes.
Conclusions:
We believe that the limited antiretroviral therapy received by the long term survivors cannot solely account for their benign clinical status. Therefore, we conclude that other factors, including gene polymorphisms that affect viral replicative capacity, account for the long term survival in some, and deduce that, as in adults, no single factor (virologic or host) can account for this clinical phenotype in all cases.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Retrovirus Life Cycles
Cytomegalovirus Disease
Respiratory Syncytial Virus Disease
Mechanisms of Retrovirus-induced Cancers

